TWO SIGMA INVESTMENTS, LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,391,309
+154.6%
95,484
+218.2%
0.01%
+200.0%
Q2 2023$1,724,675
+133.7%
30,010
+41.6%
0.00%
+100.0%
Q2 2022$738,000
-54.4%
21,200
-76.0%
0.00%
-50.0%
Q1 2021$1,619,000
-54.3%
88,375
-53.2%
0.00%
-69.2%
Q3 2020$3,544,000
+195.3%
189,010
+253.9%
0.01%
+116.7%
Q2 2020$1,200,000
+78.0%
53,410
+67.3%
0.01%
+200.0%
Q2 2019$674,000
+30.4%
31,917
+22.8%
0.00%0.0%
Q4 2018$517,000
-38.3%
26,000
-41.8%
0.00%
-33.3%
Q1 2018$838,000
-42.0%
44,676
-43.1%
0.00%
-50.0%
Q4 2016$1,445,000
-41.0%
78,456
-39.2%
0.01%
-33.3%
Q3 2016$2,449,000
+12.8%
129,086
-4.2%
0.01%0.0%
Q2 2016$2,172,000
+55.8%
134,745
+16.0%
0.01%
+28.6%
Q1 2016$1,394,000
+29.3%
116,133
+53.3%
0.01%
+40.0%
Q4 2015$1,078,000
+125.5%
75,750
+85.2%
0.01%
+150.0%
Q3 2015$478,000
-87.5%
40,905
-81.2%
0.00%
-88.9%
Q2 2015$3,826,000
+193.9%
217,641
+150.0%
0.02%
+200.0%
Q1 2015$1,302,000
+183.0%
87,057
+119.5%
0.01%
+100.0%
Q4 2014$460,00039,6590.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders